Risk reduction of severe outcomes in vaccinated COVID-19 cases: an analysis of surveillance data from Estonia, Ireland, Luxembourg and Slovakia, January to November 2021.
COVID-19
Europe Union
death
hospitalization
surveillance
vaccination
vaccine effectiveness
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
entrez:
18
2
2022
pubmed:
19
2
2022
medline:
24
2
2022
Statut:
ppublish
Résumé
Despite high COVID-19 vaccine coverage in the EU/EEA, there are increasing reports of SARS-CoV-2 infections and hospitalisations in vaccinated individuals. Using surveillance data from Estonia, Ireland, Luxembourg and Slovakia (January-November 2021), we estimated risk reduction of severe outcomes in vaccinated cases. Increasing age remains the most important driver of severity, and vaccination significantly reduces risk in all ages for hospitalisation (adjusted relative risk (aRR): 0.32; 95% confidence interval (CI): 0.26-0.39) and death (aRR: 0.20; 95% CI: 0.13-0.29).
Identifiants
pubmed: 35177166
doi: 10.2807/1560-7917.ES.2022.27.7.2200060
pmc: PMC8855507
doi:
Substances chimiques
COVID-19 Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156327
Nat Commun. 2021 Nov 4;12(1):6379
pubmed: 34737312
Euro Surveill. 2021 Oct;26(41):
pubmed: 34651577
Euro Surveill. 2021 Nov;26(47):
pubmed: 34823641
Lancet. 2021 May 15;397(10287):1819-1829
pubmed: 33964222
Euro Surveill. 2021 Dec;26(48):
pubmed: 34857068